| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/31/2006 | EP1660119A2 Multi-antigen vectors for melanoma |
| 05/31/2006 | EP1660114A1 Methods and compositions for treating disorders of the extracellular matrix |
| 05/31/2006 | EP1660113A1 A method of producing an anticoagulation effect |
| 05/31/2006 | EP1660095A2 Tricyclic parp inhibitors |
| 05/31/2006 | EP1660057A2 Combination therapy for the treatment of ocular neovascular disorders |
| 05/31/2006 | EP1660016A2 Sars nucleic acids, proteins, vaccines, and uses thereof |
| 05/31/2006 | EP1659996A2 Citrus sesquiterpene synthase, methods of production and uses thereof |
| 05/31/2006 | EP1659918A2 Antibodies directed to parathyroid hormone (pth) and uses thereof |
| 05/31/2006 | EP1659860A1 New diabetes type 2 animal model |
| 05/31/2006 | EP1659859A1 Method for producing avian chimera using spermatogonial cells and avian chimera |
| 05/31/2006 | EP1659858A2 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 05/31/2006 | EP1659855A1 Rice plants having increased tolerance to imidazolinone herbicides |
| 05/31/2006 | EP1534838A4 Transgenic bioluminescent plants |
| 05/31/2006 | EP1534739A4 Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways |
| 05/31/2006 | EP1478775A4 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins |
| 05/31/2006 | EP1476577A4 Regulated vectors for controlling dna hypermutability in eukariotic cells |
| 05/31/2006 | EP1470229B1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
| 05/31/2006 | EP1461625A4 Resistance circuit stabilization and pulse duration control systems for electroporation instruments |
| 05/31/2006 | EP1409743B1 Method and support for biological analysis using oligonucleotides comprising a marker capable of enzymatic activation |
| 05/31/2006 | EP1392847B1 A high throughput assay for identification of gene expression modifiers |
| 05/31/2006 | EP1385960B1 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour |
| 05/31/2006 | EP1352061B1 Method for inhibiting the expression of a target gene |
| 05/31/2006 | EP1346226B1 Screening method based on siah-numb interaction |
| 05/31/2006 | EP1333845A4 Treatment of t cell disorders |
| 05/31/2006 | EP1313855B1 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 05/31/2006 | EP1290224A4 Diagnosis kit for mycobacterium species identification and drug-resistance detection and manufacturing method thereof |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1261617B1 Methods for assay and detection on a microarray |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1230371B1 Method for producing recombinant interleucin-8 and interleucin-8 muteins and their use for screening il-8 receptor antagonists |
| 05/31/2006 | EP1218743B1 Layered device with capture regions for cellular analysis |
| 05/31/2006 | EP1212084B1 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 05/31/2006 | EP1210446B1 Modified ubiquitin regulatory system |
| 05/31/2006 | EP1198580B1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 05/31/2006 | EP1175489B1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same |
| 05/31/2006 | EP1171454B1 Chimeric lyssavirus nucleic acids and polypeptides |
| 05/31/2006 | EP1159436B1 Agrobacterium-mediated transformation of cotton with fibrous root explants |
| 05/31/2006 | EP1141336B1 Variants of egiii-like cellulase and compositions thereof |
| 05/31/2006 | EP1117834B1 Multiplex genotyping using fluorescent hybridization probes |
| 05/31/2006 | EP1115426B1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
| 05/31/2006 | EP1108014B1 Ehrlichia canis protein |
| 05/31/2006 | EP1108006A4 Self-contained device integrating nucleic acid extraction, amplification and detection |
| 05/31/2006 | EP1073682B1 Heparanase specific molecular probes and their use in research and medical applications |
| 05/31/2006 | EP1068341B1 Particle mediated transformation of soybean with glyphosate selection |
| 05/31/2006 | EP1056887B1 Methods for determination of length polymorphisms in dna |
| 05/31/2006 | EP1054956B1 Lipase variant |
| 05/31/2006 | EP1045027B1 Novel gene having reverse transcriptase motif |
| 05/31/2006 | EP1034280B1 Cellulase produced by actinomycetes and method of producing same |
| 05/31/2006 | EP1025235B1 Expression system |
| 05/31/2006 | EP1001028B1 Gene encoding protein having aurone synthesizing activity |
| 05/31/2006 | EP1000151B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES |
| 05/31/2006 | EP0970228B1 Methods and means for gene silencing in transgenic plants |
| 05/31/2006 | EP0941352B1 Improvements in or relating to starch content of plants |
| 05/31/2006 | EP0915156B1 IgA NEPHROPATHY-ASSOCIATED GENE |
| 05/31/2006 | EP0914437B1 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 05/31/2006 | EP0911342B1 Novel protein and process for producing the same |
| 05/31/2006 | EP0891426B1 Human bikunin |
| 05/31/2006 | EP0888456B1 Prostate specific antigen oligo-epitope peptide |
| 05/31/2006 | EP0861321B1 Phosphopantetheinyl transferases and uses thereof |
| 05/31/2006 | EP0840789B1 Transketolase-related protein |
| 05/31/2006 | EP0796338B1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |
| 05/31/2006 | EP0791076B1 Diagnostic method and kit for determining kell blood group genotype |
| 05/31/2006 | EP0757717B1 Papillomavirus vaccines |
| 05/31/2006 | EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector |
| 05/31/2006 | EP0643132B1 Alpha-1,3-fucosyltransferase |
| 05/31/2006 | EP0631630B1 Control of male fertility using externally inducible promoter sequences |
| 05/31/2006 | CN1780922A Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| 05/31/2006 | CN1780920A Gene expression suppression agents |
| 05/31/2006 | CN1780917A Promoter variants for expressing genes in a fungal cell |
| 05/31/2006 | CN1780916A Chicken RNA polymerisate I promoter and the use thereof |
| 05/31/2006 | CN1780915A Tissue specific promoters |
| 05/31/2006 | CN1780914A Methods and constructs for increasing the content of selected amino acids in seeds |
| 05/31/2006 | CN1780913A Induction of methylation of CpG sequences by dsRNA in mammalian cells |
| 05/31/2006 | CN1780912A Method for inhibiting cell growth and composition therefor |
| 05/31/2006 | CN1780911A Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 05/31/2006 | CN1780910A Method and device for the detection of mutations in isolated gene sequences of the low-density lipoprotein receptor (LDL-R) which is associated with familial hypercholesterolemia |
| 05/31/2006 | CN1780909A Method of modifying nucleotide chain |
| 05/31/2006 | CN1780907A Anti-CCR5 antibody |
| 05/31/2006 | CN1780856A Human antibodies specific for interleukin 15 (IL-15) |
| 05/31/2006 | CN1780855A Human IL-1 beta antagonists |
| 05/31/2006 | CN1780853A Secreted protein family |
| 05/31/2006 | CN1780852A Group 1 mite polypeptide variants |
| 05/31/2006 | CN1780851A Method and carrier complexes for delivering molecules to cells |
| 05/31/2006 | CN1780632A Therapy for primary and metastatic cancers |
| 05/31/2006 | CN1780554A Clinically relevant animal model of human breast cancer and VEGF involvement in desmoplastic response, tamoxifen resistance and metastasis |
| 05/31/2006 | CN1780553A Generation of plants with altered oil content |
| 05/31/2006 | CN1778933A High-officient production of recombinant adenovirus carrier |
| 05/31/2006 | CN1778932A Improvement for exogenous protein accumulation in transgene plant |
| 05/31/2006 | CN1778931A High-efficient apple gene conversion |
| 05/31/2006 | CN1778930A Fusion gene of provocative organ anti-Coccidium tenellum infection and its coding protein and use thereof |
| 05/31/2006 | CN1778929A Recombinant human platelet auxin/dry cell factor fusion protein and preparation thereof |
| 05/31/2006 | CN1778928A Transglycosyl alpha-galactoglucosidezyme gene |
| 05/31/2006 | CN1778927A Coding nucleotide sequence of cupular virus capsid protein with codon optimization and use thereof |
| 05/31/2006 | CN1778926A Modified pig propagation and respiratory syndrome virus ORF5 gene and use thereof |
| 05/31/2006 | CN1778925A Plant epidermal hair specific expression promoter |
| 05/31/2006 | CN1778924A Clone and construction for total-length FRO2 gene |
| 05/31/2006 | CN1778923A Gene sequence for human granulocyte macrophage colony stimulus factor with specific expression |
| 05/31/2006 | CN1778922A Variable area gene for single-clone antibody of anti-tumour necrotized factor with high neutralizing activity and preparation thereof |
| 05/31/2006 | CN1778921A Variable area gene for single-clone antibody of anti-tumour necrotized factor with high neutralizing activity and preparation thereof |
| 05/31/2006 | CN1778920A Antibiotic peptide gene and its yeast expression carrier |